projects:workgroups:clinicalstudy
Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision Next revision | Previous revision Last revision Both sides next revision | ||
|
projects:workgroups:clinicalstudy [2022/09/30 15:38] mikehamidi [Clinical Trials Working Group] |
projects:workgroups:clinicalstudy [2024/04/28 20:17] zhen |
||
|---|---|---|---|
| Line 10: | Line 10: | ||
| **Status**:\\ | **Status**:\\ | ||
| - | - 2020: Used a synthetic representation of the CDISC SDTM data via PHUSE Test Data. Initial guidance topics were codified but require further testing with diverse real world SDTM data. The CTWG proposals submitted to the OHDSI community in July 2020.\\ | ||
| - | - 2021: CTWG did an assessment of clinical trial data providers where SDTM data could be accessed. This eventually led to discussions with Vivli (i.e., general data usage agreements and platform feasibility evaluation). \\ | ||
| - 2022: CTWG was given access to 20 Vivli clinical study packages in the SDTM format. The CTWG team is doing an inventory of those study packages in order to prioritize SDTM-to-OMOP mappings. The existing CTWG guidance topics will be further assessed and new ones identified where necessary. \\ | - 2022: CTWG was given access to 20 Vivli clinical study packages in the SDTM format. The CTWG team is doing an inventory of those study packages in order to prioritize SDTM-to-OMOP mappings. The existing CTWG guidance topics will be further assessed and new ones identified where necessary. \\ | ||
| + | - 2021: CTWG did an assessment of clinical trial data providers where SDTM data could be accessed. This eventually led to discussions with Vivli (i.e., general data usage agreements and platform feasibility evaluation). \\ | ||
| + | - 2020: Used a synthetic representation of the CDISC SDTM data via PHUSE Test Data. Initial guidance topics were codified but require further testing with diverse real world SDTM data. The CTWG proposals submitted to the OHDSI community in July 2020.\\ | ||
| </WRAP> | </WRAP> | ||
| Line 25: | Line 25: | ||
| https://github.com/OHDSI/ClinicalTrialsWGETL | https://github.com/OHDSI/ClinicalTrialsWGETL | ||
| - | Recent WG [[https://youtu.be/ctPADsAoYpM|Presentation]] [[https://ohdsiorg.sharepoint.com/:b:/s/Workgroup-Clinicaltrials/EXbVRrl7hQNEiPhC48Zx0t4BfILfVjMiW85MtWBmGHRzFA?e=nThgMV|Slides]] | + | Recent WG Updates: [[https://youtu.be/pWW72a9A5YE|Nov. 2022 Presentation]]; [[https://youtu.be/ctPADsAoYpM|Oct. 2021 Presentation]] and [[https://ohdsiorg.sharepoint.com/:b:/s/Workgroup-Clinicaltrials/EXbVRrl7hQNEiPhC48Zx0t4BfILfVjMiW85MtWBmGHRzFA?e=nThgMV|Slides]] |
| ---- | ---- | ||
| ==== Meetings ==== | ==== Meetings ==== | ||
| + | {{:projects:workgroups:ct_wg_ohdsi2021fallsymp.png?direct&300|}} | ||
| - | **Schedule**: | + | **Bi-weekly Friday WG Meeting Schedule** is accessible on OHDSI Teams environment. \\ |
| - | Biweekly calls on Fridays, 7:30AM PT/9:30AM CT/10:30AM ET/3:30PM UK time on Teams [[https://teams.microsoft.com/l/channel/19%3acc614694401a40b4b48668bd271cc9c0%40thread.tacv2/General?groupId=176311d3-ef0e-467c-bf6f-47c7f3aa82a0&tenantId=a30f0094-9120-4aab-ba4c-e5509023b2d5|here]] | + | |
| - | //**Note on accessing Teams channel above:**\\ | + | *** Note on accessing Teams channel:**\\ |
| * If you use the Teams desktop app and have multiple accounts, ensure you are already in the OHDSI Teams account before clicking the link above\\ | * If you use the Teams desktop app and have multiple accounts, ensure you are already in the OHDSI Teams account before clicking the link above\\ | ||
| - | * Alternatively, select the "web app" button in the link above for accessing meetings on your browser// | + | * Alternatively, select the "web app" button in the link above for accessing meetings on your browser\\ |
| + | * Join our WG here if you haven't: https://ohdsi.org/join-the-journey/. | ||
| - | {{:projects:workgroups:ct_wg_ohdsi2021fallsymp.png?direct&300|}} | ||
| ---- | ---- | ||
| Line 42: | Line 42: | ||
| **WG co-leads**: | **WG co-leads**: | ||
| - | Mike Hamidi, Pfizer, US (Kamiar.Hamidi@pfizer.com) and | + | Mike Hamidi, |
| - | Zhen Lin, Robot Bacon, US (Zhen.Lin@ohdsi.org) | + | and |
| + | TBD | ||
| **Active members**\\ | **Active members**\\ | ||
| - | ^ Name ^ Organization ^ Location ^ ^ | + | ^ Name ^ Organization ^ Location ^ ^ |
| - | | Rebecca Baker | CDISC | Austin, TX, USA | | | + | | Chidi Asuzu | | USA | | |
| - | | Junn Bautista | Genentech | South San Francisco, CA, USA | | | + | | Rebecca Baker | CDISC | Austin, TX, USA | | |
| - | | Elise Berliner | | | | + | | Ian Braun | Critical Path Institute | Tucson, AZ, USA | | |
| - | | Ian Braun | Critical Path Institute | Tucson, AZ, USA | | + | | Melissa Cook | Essex Management | Boston, MA, USA | [[http://www.linkedin.com/in/mkcook|{{:wiki:linkedinicon.png?20}}]] | |
| - | | Melissa Cook | Essex Management | Boston, MA, USA | [[http://www.linkedin.com/in/mkcook|{{:wiki:linkedinicon.png?20}}]] | | + | | Diane Corey | Critical Path Institute | Tucson, AZ, USA | | |
| - | | Diane Corey | Critical Path Institute | Tucson, AZ, USA | | + | | Shital Desai | | USA | | |
| - | | Stephen Fortin | | | | + | | Kerry Goetz | National Institute of Health; \\ National Eye Institute | Bethesda, MD, USA | [[https://www.linkedin.com/in/kerrygoetz/|{{:wiki:linkedinicon.png?20}}]] | |
| - | | Kerry Goetz | National Institute of Health; \\ National Eye Institute | Bethesda, MD, USA | [[https://www.linkedin.com/in/kerrygoetz/|{{:wiki:linkedinicon.png?20}}]] | | + | | Priya Gopal | Flatiron Health | New York, NY, USA | | |
| - | | Priya Gopal | Flatiron Health | New York, NY, USA | | | + | | Mike Hamidi | | USA | [[https://www.linkedin.com/in/kamiar-mike-hamidi-0a908164/|{{:wiki:linkedinicon.png?20}}]] | |
| - | | Mike Hamidi | Pfizer | USA | [[https://www.linkedin.com/in/kamiar-mike-hamidi-0a908164/|{{:wiki:linkedinicon.png?20}}]] | | + | | Dan Hartley | | USA | | |
| - | | Michael Kallfelz | Odysseus Data Services Inc. | Berlin, Germany | [[https://www.linkedin.com/in/michael-kallfelz/|{{:wiki:linkedinicon.png?20}}]] | | + | | Ying Huang |National Institute of Health | USA | | |
| - | | Asiyah Yu Lin | National Institute of Health; \\ National Center for Ontological Research | Bethesda, MD, USA | | | + | | Asiyah Yu Lin | National Institute of Health | Bethesda, MD, USA | |
| - | | Zhen Lin | Robot Bacon | Houston, TX, USA | [[https://www.linkedin.com/in/zhen-lin/|{{:wiki:linkedinicon.png?20}}]], [[https://twitter.com/zhenLinPhDRN|{{:wiki:twittericon.png?20}}]] | | + | | Zhen Lin * | Robot Bacon | Houston, TX, USA | [[https://www.linkedin.com/in/zhen-lin/|{{:wiki:linkedinicon.png?20}}]], [[https://twitter.com/zhenLinPhDRN|{{:wiki:twittericon.png?20}}]] | |
| - | | Terrence McHugh | Critical Path Institute | Tucson, AZ, USA | | + | | Zhixin Lun | University of Colorado Anschutz Medical Campus | Aurora, CO, USA | | |
| - | | Daniel Olson | Critical Path Institute | Tucson, AZ, USA | | + | | Terrence McHugh | Critical Path Institute | Tucson, AZ, USA | | |
| - | | Katy Sadowski | TrialSpark | New York, NY, USA | | | + | | Priya Meghrajani | Talosix | Seattle, WA, USA | | |
| - | | Philip Solovyev | Odysseus Data Services Inc. | St. Petersburg, Russia | | | + | | Pam Nesbitt | | USA | | |
| - | | Cynthia Sung | Bill & Melinda Gates Medical Research Institute | Seattle, WA, USA| | + | | Paul Orona | | USA | | |
| - | | Ramona Walls | Critical Path Institute | Tucson, AZ, USA | [[https://www.linkedin.com/in/ramona-walls-41aa7599/|{{:wiki:linkedinicon.png?20}}]], [[https://twitter.com/Ramona_Walls|{{:wiki:twittericon.png?20}}]], [[https://github.com/ramonawalls|{{:wiki:githubicon.png?15}}]] | | + | | Daniel Olson | Critical Path Institute | Tucson, AZ, USA | | |
| - | | Tom Walpole | Trials.ai | San Diego, CA, USA | | | + | | Katy Sadowski | TrialSpark | New York, NY, USA | | |
| - | | Kenneth Wilkins | National Institute of Health | Bethesda, MD, USA | | | + | | Philip Solovyev | Odysseus Data Services Inc. | Vilnius, Lithuania | [[https://www.linkedin.com/in/filippsolovev|{{:wiki:linkedinicon.png?20}}]] | |
| - | | Ariana Winder | nPhase, REDCap Cloud | Bellefonte, PA, USA | [[https://www.linkedin.com/in/amwinder/|{{:wiki:linkedinicon.png?20}}]] | | + | | Cynthia Sung | OHDSI | Seattle, WA, USA | [[https://www.linkedin.com/in/cynthia-sung-phd-fcp-ba01703/|{{:wiki:linkedinicon.png?20}}]] | |
| - | | Qi Yang | IQVIA | Plymouth Meeting, PA, USA | | | + | | Ramona Walls | Critical Path Institute | Tucson, AZ, USA | [[https://www.linkedin.com/in/ramona-walls-41aa7599/|{{:wiki:linkedinicon.png?20}}]], [[https://twitter.com/Ramona_Walls|{{:wiki:twittericon.png?20}}]], [[https://github.com/ramonawalls|{{:wiki:githubicon.png?15}}]] | |
| - | | Stella Zhu | Bill & Melinda Gates Medical Research Institute | Seattle, WA, USA| | + | | Tom Walpole * | ZS Associates | Princeton, NJ, USA | | |
| + | | Kenneth Wilkins | National Institute of Health | Bethesda, MD, USA | | | ||
| + | | Ying Xiao | Penn Medicine, University of Pennsylvania | Philadelphia, PA, USA | | | ||
| + | | Qi Yang | IQVIA | Plymouth Meeting, PA, USA | | | ||
| ---- | ---- | ||
| Line 81: | Line 85: | ||
| | Eldar Allakhverdiiev | Odysseus Data Services Inc. | Cambridge, MA, USA| ^ | | Eldar Allakhverdiiev | Odysseus Data Services Inc. | Cambridge, MA, USA| ^ | ||
| | Sonia Araujo * | IQVIA | London, UK | | | Sonia Araujo * | IQVIA | London, UK | | ||
| + | | Junn Bautista | Genentech | South San Francisco, CA, USA | | | ||
| + | | Elise Berliner | | | | ||
| | Ted Bebi | Medidata | Boston, MA, USA | | | Ted Bebi | Medidata | Boston, MA, USA | | ||
| | Lina Clover | SAS | Raleigh-Durham, NC, USA | | | Lina Clover | SAS | Raleigh-Durham, NC, USA | | ||
| Line 86: | Line 92: | ||
| | Shawn Dolley | Open Global Health | Arlington, Virginia, USA | | | Shawn Dolley | Open Global Health | Arlington, Virginia, USA | | ||
| | Rhonda Facile | CDISC | Austin, Texas, USA | | | Rhonda Facile | CDISC | Austin, Texas, USA | | ||
| + | | Stephen Fortin | | | | ||
| | Vojtech Huser | National Library of Medicine,\\ National Institutes of Health | Bethesda, MD, USA | | | Vojtech Huser | National Library of Medicine,\\ National Institutes of Health | Bethesda, MD, USA | | ||
| + | | Michael Kallfelz | Odysseus Data Services Inc. | Berlin, Germany | [[https://www.linkedin.com/in/michael-kallfelz/|{{:wiki:linkedinicon.png?20}}]] | | ||
| | Gregory Klebanov | Odysseus Data Services Inc. | Cambridge, MA, USA | | | Gregory Klebanov | Odysseus Data Services Inc. | Cambridge, MA, USA | | ||
| | Bess LeRoy | CDISC | Tucson, AZ, USA | | | Bess LeRoy | CDISC | Tucson, AZ, USA | | ||
| - | | James Liddil | M2Gen | Tampa, FL, USA | | + | | James Liddil | M2Gen | Tampa, FL, USA | |
| | Maxim Moinat | The Hyve | Utrecht, The Netherlands | | | Maxim Moinat | The Hyve | Utrecht, The Netherlands | | ||
| | Alexandra Orlova | Odysseus Data Services Inc. | Cambridge, MA, USA | | | Alexandra Orlova | Odysseus Data Services Inc. | Cambridge, MA, USA | | ||
| Line 97: | Line 105: | ||
| | Emma Vos | The Hyve | Utrecht, The Netherlands| | | Emma Vos | The Hyve | Utrecht, The Netherlands| | ||
| | Andrew Williams | Tufts Institute for Clinical Research \\ and Health Policy Studies | Boston, MA, USA | | | Andrew Williams | Tufts Institute for Clinical Research \\ and Health Policy Studies | Boston, MA, USA | | ||
| + | | Ariana Winder | Javara Research | State College, Pennsylvania, USA | [[https://www.linkedin.com/in/amwinder/|{{:wiki:linkedinicon.png?20}}]] | | ||
| + | | Stella Zhu | Bill & Melinda Gates Medical Research Institute | Seattle, WA, USA| | ||
| * Past leads | * Past leads | ||
| Line 102: | Line 112: | ||
| ---- | ---- | ||
| - | **Want to contribute to the group?** [[https://ohdsi.org/join-the-journey/|Opt-in here]]. | + | **Want to contribute to the group?** [[https://ohdsi.org/join-the-journey/|Opt-in here]]. \\ |
| + | [[https://ohdsi.org/this-week-in-ohdsi/|Click here to catch up recent calls and job openings]] | ||
| ~~NOTOC~~ | ~~NOTOC~~ | ||
projects/workgroups/clinicalstudy.txt · Last modified: 2024/04/28 20:17 by zhen
Page Tools
